238 related articles for article (PubMed ID: 21778574)
1. BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.
Diaz-Cruz ES; Cabrera MC; Nakles R; Rutstein BH; Furth PA
Breast Dis; 2010; 32(1-2):85-97. PubMed ID: 21778574
[TBL] [Abstract][Full Text] [Related]
2. Triple negative tumours: a critical review.
Reis-Filho JS; Tutt AN
Histopathology; 2008 Jan; 52(1):108-18. PubMed ID: 18171422
[TBL] [Abstract][Full Text] [Related]
3. Triple-negative breast cancer: what the radiologist needs to know.
Whitman GJ; Albarracin CT; Gonzalez-Angulo AM
Semin Roentgenol; 2011 Jan; 46(1):26-39. PubMed ID: 21134526
[No Abstract] [Full Text] [Related]
4. Clinical implications for BRCA gene mutation in breast cancer.
Xu J; Wang B; Zhang Y; Li R; Wang Y; Zhang S
Mol Biol Rep; 2012 Mar; 39(3):3097-102. PubMed ID: 21691706
[TBL] [Abstract][Full Text] [Related]
5. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
Venkitaraman R
Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996
[TBL] [Abstract][Full Text] [Related]
6. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
7. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options for triple-negative breast cancers with defective homologous recombination.
Jaspers JE; Rottenberg S; Jonkers J
Biochim Biophys Acta; 2009 Dec; 1796(2):266-80. PubMed ID: 19616605
[TBL] [Abstract][Full Text] [Related]
9. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.
Collins LC; Martyniak A; Kandel MJ; Stadler ZK; Masciari S; Miron A; Richardson AL; Schnitt SJ; Garber JE
Am J Surg Pathol; 2009 Jul; 33(7):1093-7. PubMed ID: 19390427
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of triple negative [basal-like/claudin low] breast cancer.
Herschkowitz JI; Lubet R
Breast Dis; 2010; 32(1-2):63-71. PubMed ID: 21965308
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of triple-negative breast cancer.
de Ruijter TC; Veeck J; de Hoon JP; van Engeland M; Tjan-Heijnen VC
J Cancer Res Clin Oncol; 2011 Feb; 137(2):183-92. PubMed ID: 21069385
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.
Kaur P; Nagaraja GM; Zheng H; Gizachew D; Galukande M; Krishnan S; Asea A
BMC Cancer; 2012 Mar; 12():120. PubMed ID: 22452810
[TBL] [Abstract][Full Text] [Related]
13. Few positives for triple-negative breast cancer.
Hede K
J Natl Cancer Inst; 2011 Apr; 103(7):532-3. PubMed ID: 21436063
[No Abstract] [Full Text] [Related]
14. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
[TBL] [Abstract][Full Text] [Related]
16. What is triple-negative breast cancer?
Irvin WJ; Carey LA
Eur J Cancer; 2008 Dec; 44(18):2799-805. PubMed ID: 19008097
[TBL] [Abstract][Full Text] [Related]
17. Triple-negative breast cancers and the human mammary epithelial cell hierarchy.
Ganesan S; Karantza V; Oza J; Toppmeyer D
Breast Dis; 2010; 32(1-2):49-61. PubMed ID: 22045329
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J
PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025
[TBL] [Abstract][Full Text] [Related]
19. First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report.
Ripamonti CB; Colombo M; Mondini P; Siranoush M; Peissel B; Bernard L; Radice P; Carcangiu ML
BMC Cancer; 2013 Feb; 13():46. PubMed ID: 23374397
[TBL] [Abstract][Full Text] [Related]
20. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
Moestue SA; Borgan E; Huuse EM; Lindholm EM; Sitter B; Børresen-Dale AL; Engebraaten O; Maelandsmo GM; Gribbestad IS
BMC Cancer; 2010 Aug; 10():433. PubMed ID: 20716336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
